Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$575k
2 rounds on record
Latest round
$575k
Venture round · Mar 2026 · 7 mo ago
Grants
$274k
1 grant · CORDIS
Backers
2
SOSV, Robin Hood Ventures
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2026 | $575k | — | SEC Form D |
| Grant | Dec 2023 | $274k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | BioLattice Ophthalmics, Inc, | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Amelia ZellanderExecutive Officer, DirectorSEC Form D
Linda AlunkalExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
SOSV 
Robin Hood Ventures Overview
BioLattice Ophthalmics, Inc. is addressing the need for tissue repair solutions, beginning with the cornea.
People
Amelia Zellander
Executive Officer, Director
Linda Alunkal
Executive Officer, Director
Gregory Jackson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Philadelphia
United States
HQ